miR-146a promoted breast cancer proliferation and invasion by regulating NM23-H1
Author:
Affiliation:
1. Breast Tumor Department, 3rd Hospital of Nanchang, No. 2 Xiangshan South Road, Xihu District, Nanchang, Jiangxi, China
2. Oncology Department, Jiangxi Provincial Chest Hospital, No. 346, Dieshan Road, East Lake District, Nanchang, Jiangxi, China
Abstract
Publisher
Oxford University Press (OUP)
Subject
Molecular Biology,Biochemistry,General Medicine
Link
http://academic.oup.com/jb/advance-article-pdf/doi/10.1093/jb/mvz079/30258829/mvz079.pdf
Reference19 articles.
1. Effects of age on the detection and management of breast cancer;Mcguire;Cancers (Basel),2015
2. Identification of tissue-specific microRNAs from mouse;Lagos-Quintana;Curr. Biol,2002
3. MicroRNAs: target recognition and regulatory functions;Bartel;Cell,2009
4. Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers;Garcia;EMBO Mol. Med.,2011
5. Effect of miR-146a-5p on proliferation and metastasis of triple-negative breast cancer via regulation of SOX5;Si;Exp. Ther. Med.,2018
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Histidine Phosphorylation: Protein Kinases and Phosphatases;International Journal of Molecular Sciences;2024-07-21
2. TNFRSF18 Promotes the Proliferation of Breast Cancer Cells by Inhibiting UBL3;J BIOL REG HOMEOS AG;2024
3. NSUN6 Regulates NM23-H1 Expression in an m5C Manner to Affect Epithelial-Mesenchymal Transition in Lung Cancer;Medical Principles and Practice;2023-11-29
4. A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle‐related genes and miRNAs in triple‐negative breast cancer cells;Molecular Carcinogenesis;2023-10-03
5. miR-29a-SIRT1-Wnt/β-Catenin Axis Regulates Tumor Progression and Survival in Hepatocellular Carcinoma;Biochemical Genetics;2023-09-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3